Quantitative determination of perifosine, a novel alkylphosphocholine anticancer agent, in human plasma by reversed-phase liquid chromatography-electrospray mass spectrometry.

[1]  M. Berger,et al.  Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines. , 1999, Cancer letters.

[2]  H. Bartelink,et al.  Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. , 1999, Cancer research.

[3]  J. Henion,et al.  High-throughput bioanalytical LC/MS/MS determination of benzodiazepines in human urine: 1000 samples per 12 hours. , 1999, Analytical Chemistry.

[4]  D. Berkovic,et al.  Cytotoxic etherphospholipid analogues. , 1998, General pharmacology.

[5]  J. Brouwers,et al.  Quantitative analysis of phosphatidylcholine molecular species using HPLC and light scattering detection. , 1998, Journal of lipid research.

[6]  M. Berger,et al.  Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells , 1997, Cancer Chemotherapy and Pharmacology.

[7]  R. Vreeken,et al.  Rapid target analysis of microcontaminants in water by on-line single-short-column liquid chromatography combined with atmospheric pressure chemical ionization tandem mass spectrometry. , 1997, Journal of chromatography. A.

[8]  H. Grunicke,et al.  Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction. , 1996, Advances in enzyme regulation.

[9]  M. Mareel,et al.  Capillary gas chromatography of hexadecylphosphocholine in Caco-2T cells and cell culture media. , 1995, Analytical biochemistry.

[10]  H Y Kim,et al.  Liquid chromatography/mass spectrometry of phospholipids using electrospray ionization. , 1994, Analytical chemistry.

[11]  H. Sindermann,et al.  Phase II Trial of Orally Administered Miltefosine in Advanced Colorectal Cancer , 1993 .

[12]  L. Edler,et al.  Daily Oral Miltefosine (Hexadecylphosphocholine) in Patients with Advanced Breast Cancer: A Phase II Study , 1993 .